Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $41.79 in the prior trading day, Genpact Ltd (NYSE: G) closed at $42.21, up 1.01%. In other words, the price has increased by $1.01 from its previous closing price. On the day, 1.46 million shares were traded. G stock price reached its highest trading level at $42.28 during the session, while it also had its lowest trading level at $41.605.
Ratios:
Our goal is to gain a better understanding of G by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.00. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.39.
On February 07, 2025, TD Cowen Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $45 to $60.
Jefferies Upgraded its Hold to Buy on January 21, 2025, whereas the target price for the stock was revised from $44 to $55.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 12 ’25 when Mehta Piyush sold 76,902 shares for $42.58 per share. The transaction valued at 3,274,487 led to the insider holds 134,880 shares of the business.
Kalra Balkrishan sold 55,000 shares of G for $2,384,850 on Sep 11 ’25. The President and CEO now owns 295,246 shares after completing the transaction at $43.36 per share. On Sep 12 ’25, another insider, PIYUSH MEHTA, who serves as the Officer of the company, bought 76,902 shares for $42.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, G now has a Market Capitalization of 7355939840 and an Enterprise Value of 8219649024. As of this moment, Genpact’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.00, and their Forward P/E ratio for the next fiscal year is 10.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.49 while its Price-to-Book (P/B) ratio in mrq is 2.84. Its current Enterprise Value per Revenue stands at 1.668 whereas that against EBITDA is 10.015.
Stock Price History:
The Beta on a monthly basis for G is 0.91, which has changed by 0.076511145 over the last 52 weeks, in comparison to a change of 0.1529237 over the same period for the S&P500. Over the past 52 weeks, G has reached a high of $56.76, while it has fallen to a 52-week low of $37.82. The 50-Day Moving Average of the stock is -3.48%, while the 200-Day Moving Average is calculated to be -8.31%.
Shares Statistics:
The stock has traded on average 1.76M shares per day over the past 3-months and 2069100 shares per day over the last 10 days, according to various share statistics. A total of 174.26M shares are outstanding, with a floating share count of 159.87M. Insiders hold about 8.27% of the company’s shares, while institutions hold 95.26% stake in the company. Shares short for G as of 1757894400 were 7043861 with a Short Ratio of 4.00, compared to 1755216000 on 6887138. Therefore, it implies a Short% of Shares Outstanding of 7043861 and a Short% of Float of 4.62.
Dividends & Splits
In the trailing 12 months, G’s forward annual dividend rate was 0.645, compared to 0.66 this year. Against a Trailing Annual Dividend Yield of 0.015434314. The stock’s 5-year Average Dividend Yield is 1.22.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 8.0 analysts currently analyzing and rating the stock of Genpact Ltd (G).The consensus estimate for the next quarter is $0.93, with high estimates of $0.94 and low estimates of $0.91.
Analysts are recommending an EPS of between $3.57 and $3.52 for the fiscal current year, implying an average EPS of $3.55. EPS for the following year is $3.88, with 10.0 analysts recommending between $3.97 and $3.82.
Revenue Estimates
8 analysts predict $1.27B in revenue for . The current quarter. It ranges from a high estimate of $1.27B to a low estimate of $1.26B. As of . The current estimate, Genpact Ltd’s year-ago sales were $1.21BFor the next quarter, 8 analysts are estimating revenue of $1.29B. There is a high estimate of $1.3B for the next quarter, whereas the lowest estimate is $1.27B.
A total of 10 analysts have provided revenue estimates for G’s current fiscal year. The highest revenue estimate was $5.04B, while the lowest revenue estimate was $5.01B, resulting in an average revenue estimate of $5.02B. In the same quarter a year ago, actual revenue was $4.77BBased on 10 analysts’ estimates, the company’s revenue will be $5.36B in the next fiscal year. The high estimate is $5.45B and the low estimate is $5.26B.
